Search Results - "Rodríguez, Ana Cecilia"

Human Papillomavirus Types by Age in Cervical Cancer Precursors: Predominance of Human Papillomavirus 16 in Young Women by PORRAS, Carolina, CECILIA RODRIGUEZ, Ana, HILDESHEIM, Allan, HERRERO, Rolando, GONZALEZ, Paula, WACHOLDER, Sholom, BURK, Robert D, SCHIFFMAN, Mark

“…In a population-based study conducted in Guanacaste, Costa Rica, we investigated the human papillomavirus (HPV) types detected in 233 cases of cervical…”
Get full text

Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer by Wang, Sophia S., Bratti, M. Concepcion, Rodríguez, Ana Cecilia, Herrero, Rolando, Burk, Robert D., Porras, Carolina, González, Paula, Sherman, Mark E., Wacholder, Sholom, Lan, Z. Elizabeth, Schiffman, Mark, Chanock, Stephen J., Hildesheim, Allan

“…Background. We examined host genetic factors to identify those more common in individuals whose human papillomavirus (HPV) infections were most likely to…”
Get full text

Evaluation of the FTA Carrier Device for Human Papillomavirus Testing in Developing Countries by GONZALEZ, Paula, CORTES, Bernal, MELCHERS, Willem, QUINT, Wim, KREIMER, Aimée R, PORRAS, Carolina, CECILIA RODRIGUEZ, Ana, JIMENEZ, Silvia, HERRERO, Rolando, STRUIJK, Linda, HILDESHEIM, Allan

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women by GARCIA-PINERES, Alfonso J, HILDESHEIM, Allan, BURK, Robert D, HILDESHEIM, Mariana, FREER, Enrique, BONILLA, José, BRATTI, Concepcion, BERZOFSKY, Jay A, PINTO, Ligia A, HERRERO, Rolando, TRIVETT, Matthew, WILLIAMS, Marcus, ATMETLLA, Ivannia, RAMIREZ, Margarita, VILLEGAS, Maricela, SCHIFFMAN, Mark, RODRIGUEZ, Ana Cecilia

“…The development of cervical cancer and its precursors are linked to persistent infection with oncogenic types of human papillomavirus (HPV). Host immune…”
Get full text

The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing by Desai, Kanan T., Befano, Brian, Xue, Zhiyun, Kelly, Helen, Campos, Nicole G., Egemen, Didem, Gage, Julia C., Rodriguez, Ana‐Cecilia, Sahasrabuddhe, Vikrant, Levitz, David, Pearlman, Paul, Jeronimo, Jose, Antani, Sameer, Schiffman, Mark, de Sanjosé, Silvia

“…Abstract There is limited access to effective cervical cancer screening programs in many resource‐limited settings, resulting in continued high cervical cancer…”
Get full text

Cervical cancer prevention in upper middle-income countries by Rodríguez, Ana Cecilia, Salmerón, Jorge

“…Abstract The manuscripts by Tota et al. and by Rossi et al., in this issue of Preventive Medicine provide ample evidence regarding the urgent need to switch to…”
Get full text

Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens by Quint, Koen, Porras, Carolina, Safaeian, Mahboobeh, González, Paula, Hildesheim, Allan, Quint, Wim, van Doorn, Leen-Jan, Silva, Sandra, Melchers, Willem, Schiffman, Mark, Rodríguez, Ana Cecilia, Wacholder, Sholom, Freer, Enrique, Cortes, Bernal, Herrero, Rolando

“…The aims of this study were to compare a novel PCR-based Chlamydia trachomatis detection and genotyping (Ct-DT) assay with the FDA-approved, commercially…”
Get full text

Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections by Rodríguez, Ana Cecilia, Schiffman, Mark, Herrero, Rolando, Wacholder, Sholom, Hildesheim, Allan, Castle, Philip E., Solomon, Diane, Burk, Robert

“…Health professionals and the public need to understand the natural history of human papillomavirus (HPV) infections of the cervix to best use the information…”
Get full text

Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs by Desai, Kanan T., Hansen, Natasha, Rodriguez, Ana-Cecilia, Befano, Brian, Egemen, Didem, Gage, Julia C., Wentzensen, Nicolas, Lopez, Catya, Jeronimo, Jose, de Sanjose, Silvia, Schiffman, Mark

“…Visual assessment is currently used for primary screening or triage of screen-positive individuals in cervical cancer screening programs. Most guidelines…”
Get full text

Heterogeneity in CIN3 diagnosis by Schiffman, Mark, Rodríguez, Ana Cecilia

Get full text

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial by Safaeian, Mahboobeh, Sampson, Joshua N, Pan, Yuanji, Porras, Carolina, Kemp, Troy J, Herrero, Rolando, Quint, Wim, van Doorn, Leen Jan, Schussler, John, Lowy, Douglas R, Schiller, John, Schiffman, Mark T, Rodriguez, Ana Cecilia, Gail, Mitchell H, Hildesheim, Allan, Gonzalez, Paula, Pinto, Ligia A, Kreimer, Aimée R

“…Previously, we demonstrated similar human papillomavirus (HPV)16/18 vaccine efficacy estimates and stable HPV16/18 antibody levels four years postvaccination…”
Get full text

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica by Herrero, Rolando, Quint, Wim, Hildesheim, Allan, Gonzalez, Paula, Struijk, Linda, Katki, Hormuzd A, Porras, Carolina, Schiffman, Mark, Rodriguez, Ana Cecilia, Solomon, Diane, Jimenez, Silvia, Schiller, John T, Lowy, Douglas R, van Doorn, Leen-Jan, Wacholder, Sholom, Kreimer, Aimée R

“…Human papillomavirus (HPV) infection, particularly with type 16, causes a growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in…”
Get full text

Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease by Chaturvedi, Anil K., Katki, Hormuzd A., Hildesheim, Allan, Rodríguez, Ana Cecilia, Quint, Wim, Schiffman, Mark, Van Doorn, Leen-Jan, Porras, Carolina, Wacholder, Sholom, Gonzalez, Paula, Sherman, Mark E., Herrero, Rolando

“…Objective. We investigated coinfection patterns for 25 human papillomavirus (HPV) types and assessed the risk conferred by multiple HPV types toward cervical…”
Get full text

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial by Tsang, Sabrina H, Sampson, Joshua N, Schussler, John, Porras, Carolina, Wagner, Sarah, Boland, Joseph, Cortes, Bernal, Lowy, Douglas R, Schiller, John T, Schiffman, Mark, Kemp, Troy J, Rodriguez, Ana Cecilia, Quint, Wim, Gail, Mitchell H, Pinto, Ligia A, Gonzalez, Paula, Hildesheim, Allan, Kreimer, Aimée R, Herrero, Rolando

“…Abstract Background The Costa Rica HPV Vaccine Trial has documented cross-protection of the bivalent HPV vaccine against HPV31/33/45 up to 7 years after…”
Get full text

Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial by Befano, Brian, Campos, Nicole G, Egemen, Didem, Herrero, Rolando, Schiffman, Mark, Porras, Carolina, Lowy, Douglas R, Rodriguez, Ana Cecilia, Schiller, John T, Ocampo, Rebecca, Hildesheim, Allan, Sampson, Joshua N, Das, Shrutikona, Kreimer, Aimée R, Cheung, Li C

“…Abstract Background The World Health Organization recommends a 1- or 2-dose human papillomavirus (HPV) vaccination schedule for females aged 9 to 20 years…”
Get full text

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection by Rodríguez, Ana Cecilia, Schiffman, Mark, Herrero, Rolando, Hildesheim, Allan, Bratti, Concepción, Sherman, Mark E., Solomon, Diane, Guillén, Diego, Alfaro, Mario, Morales, Jorge, Hutchinson, Martha, Katki, Hormuzd, Cheung, Li, Wacholder, Sholom, Burk, Robert D.

“…Background The natural history of human papillomavirus (HPV) infections in older women is critical for preventive strategies, including vaccination and…”
Get full text

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial by Kreimer, Aimée R, Dr, González, Paula, MD, Katki, Hormuzd A, PhD, Porras, Carolina, MS, Schiffman, Mark, MD, Rodriguez, Ana Cecilia, MD, Solomon, Diane, MD, Jiménez, Silvia, MS, Schiller, John T, PhD, Lowy, Douglas R, MD, van Doorn, Leen-Jan, PhD, Struijk, Linda, PhD, Quint, Wim, PhD, Chen, Sabrina, BS, Wacholder, Sholom, PhD, Hildesheim, Allan, PhD, Herrero, Rolando, MD

“…Summary Background Anal cancer remains rare (incidence of about 1·5 per 100 000 women yearly), but rates are increasing in many countries. Human papillomavirus…”
Get full text

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes by Wagner, Sarah, Roberson, David, Boland, Joseph, Kreimer, Aimée R, Yeager, Meredith, Cullen, Michael, Mirabello, Lisa, Dunn, S Terence, Walker, Joan, Zuna, Rosemary, Porras, Carolina, Cortes, Bernal, Sampson, Joshua, Herrero, Rolando, Rodriguez, Ana Cecilia, Quint, Wim, Van Doorn, Leen-Jan, Hildesheim, Allan, Schiffman, Mark, Wentzensen, Nicolas

“…Abstract Background Human papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human…”
Get full text

The cervical microbiome over 7 years and a comparison of methodologies for its characterization by Smith, Benjamin C, McAndrew, Thomas, Chen, Zigui, Harari, Ariana, Barris, David M, Viswanathan, Shankar, Rodriguez, Ana Cecilia, Castle, Phillip, Herrero, Rolando, Schiffman, Mark, Burk, Robert D

“…The rapidly expanding field of microbiome studies offers investigators a large choice of methods for each step in the process of determining the microorganisms…”
Get full text

Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections by Harari, Ariana, Chen, Zigui, Rodríguez, Ana Cecilia, Hildesheim, Allan, Porras, Carolina, Herrero, Rolando, Wacholder, Sholom, Panagiotou, Orestis A., Befano, Brian, Burk, Robert D., Schiffman, Mark

“…Background. Results from the Costa Rica Vaccine Trial (CVT) demonstrated partial cross-protection by the bivalent human papillomavirus (HPV) vaccine, which…”
Get full text